Compare EZPW & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZPW | NEO |
|---|---|---|
| Founded | 1989 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1996 | 2008 |
| Metric | EZPW | NEO |
|---|---|---|
| Price | $32.62 | $16.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $30.67 | $13.38 |
| AVG Volume (30 Days) | 1.0M | ★ 2.4M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.09 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $747,954,000.00 | N/A |
| Revenue This Year | $25.40 | $10.63 |
| Revenue Next Year | $11.33 | $9.73 |
| P/E Ratio | $17.43 | ★ N/A |
| Revenue Growth | ★ 2.39 | N/A |
| 52 Week Low | $15.96 | $6.38 |
| 52 Week High | $37.13 | $16.92 |
| Indicator | EZPW | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 61.34 | 64.60 |
| Support Level | $30.94 | $11.49 |
| Resistance Level | $36.88 | N/A |
| Average True Range (ATR) | 1.50 | 0.59 |
| MACD | 0.36 | -0.03 |
| Stochastic Oscillator | 89.58 | 95.00 |
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.